Christoph Mamot
- Molecular Biology top 10%
- Biomaterials top 1%
- Oncology top 5%
- Radiology, Nuclear Medicine and Imaging top 2%
- Biomedical Engineering top 5%
- Co-authors
- John W. ParkDaryl C. DrummondDmitri B. KirpotinKeelung HongCharles O. NobleChristoph RochlitzReto RitschardJames D. Marks
- Topics
- Lymphoma Diagnosis and Treatment (14 papers)Monoclonal and Polyclonal Antibodies Research (13 papers)Nanoparticle-Based Drug Delivery (12 papers)
- Partner nations
- SwitzerlandUnited StatesItaly
In The Last Decade
Christoph Mamot
46 papers receiving 2.2k citations
Peers
Comparison fields: 5 of 92
- Molecular Biology 1.0k
- Biomaterials 958
- Oncology 578
- Radiology, Nuclear Medicine and Imaging 570
- Biomedical Engineering 530
Countries citing papers authored by Christoph Mamot
This map shows the geographic impact of Christoph Mamot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christoph Mamot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christoph Mamot more than expected).
Fields of papers citing papers by Christoph Mamot
This network shows the impact of papers produced by Christoph Mamot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christoph Mamot. The network helps show where Christoph Mamot may publish in the future.
Co-authorship network of co-authors of Christoph Mamot
This figure shows the co-authorship network connecting the top 25 collaborators of Christoph Mamot. A scholar is included among the top collaborators of Christoph Mamot based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christoph Mamot. Christoph Mamot is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 10 | |
| 2 | 20 | |
| 3 | 4 | |
| 4 | 8 | |
| 5 | 16 | |
| 6 | 57 | |
| 7 | 7 | |
| 8 | 19 | |
| 9 | 18 | |
| 10 | 31 | |
| 11 | 5 | |
| 12 | 4 | |
| 13 | 77 | |
| 14 | 54 | |
| 15 | 14 | |
| 16 | 110 | |
| 17 | 119 | |
| 18 | 135 | |
| 19 | 17 | |
| 20 | 1 |
About Christoph Mamot
Christoph Mamot is a scholar working on Microbiology, Biomaterials and Oncology, having authored 49 papers that have together received 2.3k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (14 papers), Monoclonal and Polyclonal Antibodies Research (13 papers) and Nanoparticle-Based Drug Delivery (12 papers). The work is most often cited by research in Biomaterials (958 citations), Radiology, Nuclear Medicine and Imaging (570 citations) and Genetics (233 citations). Christoph Mamot has collaborated with scholars based in Switzerland, United States and Italy. Frequent co-authors include John W. Park, Daryl C. Drummond, Dmitri B. Kirpotin, Keelung Hong, Charles O. Noble, Christoph Rochlitz, Reto Ritschard, James D. Marks, Richard Herrmann and Andreas Wicki. Their work appears in journals such as Journal of Clinical Oncology, Blood and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.